Publications by authors named "Astrid Seidl"

Aim Of The Study: The Federal Joint Committee has decided to introduce organized cervical carcinoma screening in 2020. The present work describes the development of decision aids that will be sent to women in this program.

Methods: A systematic search for qualitative studies and surveys was conducted to gather information on experiences, attitudes and information needs.

View Article and Find Full Text PDF

Background And Purpose: The German Institute for Quality and Efficiency in Health Care (IQWiG) previously tested two preference elicitation methods in pilot projects and regarded them as generally feasible for prioritizing outcome-specific results of benefit assessment. The present study aimed to investigate the feasibility of completing a discrete choice experiment (DCE) within 3 months and to determine the relative importance of attributes of periodontal disease and its treatment.

Patients And Methods: This preference elicitation was conducted alongside the IQWiG benefit assessment of systematic treatments of periodontal diseases.

View Article and Find Full Text PDF

Estimating input costs for Markov models in health economic evaluations requires health state-specific costing. This is a challenge in mental illnesses such as depression, as interventions are not clearly related to health states. We present a hybrid approach to health state-specific cost estimation for a German health economic evaluation of antidepressants.

View Article and Find Full Text PDF

Background: Cost-of-illness (CoI) studies are important instruments for estimating the socioeconomic burden of specified diseases. CoI studies provide important information about the cost structure of a disease, the resulting research need, approaches to improve aspects of care and, monetary consequences from different perspectives. This information can be useful for healthcare research and health policy.

View Article and Find Full Text PDF
Article Synopsis
  • * Development of the efficiency frontier approach was necessary to meet legal requirements, but ongoing health care reforms and changing objectives have altered the landscape.
  • * Current drug price negotiations depend on early benefit assessments from pharmaceutical companies, raising questions about the SHI system’s sustainability and its need to utilize health economic evaluations for various interventions.
View Article and Find Full Text PDF